Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck merck Master Trust — Fixed Income Securities ($M) ($M)
Form 11-K Note 4 Master Trust
Latest, FY2025
406,994
Period ended Dec 31, 2025
Change on a year earlier
+5.4%
386,182 in FY2024
History
8 years
Since FY2018
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Merck Master Trust — Fixed Income Securities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 406,994 | +5.4% | Form 11-K (mrk-20260624.htm, filed 2026-06-24) ↗ |
| FY2024 | Dec 31, 2024 | 386,182 | +15.7% | Form 11-K (mrk-20260624.htm, filed 2026-06-24) ↗ |
| FY2023 | Dec 31, 2023 | 333,751 | -2.9% | Form 11-K (a11-k_merckussavingsplanye.htm, filed 2025-06-27) ↗ |
| FY2022 | Dec 31, 2022 | 343,618 | -18.5% | Form 11-K (a11-k_merckussavingsplanye.htm, filed 2024-06-25) ↗ |
| FY2021 | Dec 31, 2021 | 421,467 | +17.0% | Form 11-K (a11-k_merckussavingsplanye.htm, filed 2023-06-27) ↗ |
| FY2020 | Dec 31, 2020 | 360,208 | +21.6% | Form 11-K (a11-k_merckussavingsplanye.htm, filed 2022-06-15) ↗ |
| FY2019 | Dec 31, 2019 | 296,144 | +11.0% | Form 11-K (a11-k_merckussavingsplanye.htm, filed 2021-06-16) ↗ |
| FY2018 | Dec 31, 2018 | 266,899 | – | Form 11-K (a11-k_merckussavingsplanye.htm, filed 2020-06-23) ↗ |
Cite this data
StockData. (2026). Merck Merck Master Trust — Fixed Income Securities ($M) ($M), annual FY2018–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/plan11k_mt_fi
See every metric in the Merck KPI table. Data updated Oct 26, 2026.